title: Molecular profile of gastric cancer as a basis of individualized treatment and prognosis of disease outcome.
authors.affiliation: R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, NAS of Ukraine, Kyiv 03022, Ukraine. oncom@onconet.kiev.ua
authors.forename: D V
authors.initials: DV
authors.lastname: Demash
authors.forename: V M
authors.initials: VM
authors.lastname: Bazas
authors.forename: N Yu
authors.initials: NY
authors.lastname: Lukianova
authors.forename: D O
authors.initials: DO
authors.lastname: Rozumiy
authors.forename: V F
authors.initials: VF
authors.lastname: Chekhun
mesh_terms: D000911:Antibodies, Monoclonal / Q000276:immunology; D014408:Biomarkers, Tumor / Q000032:analysis*; D015820:Cadherins / Q000032:analysis; D051177:Catenins / Q000032:analysis; D006801:Humans; D025202:Molecular Diagnostic Techniques; D057285:Precision Medicine / Q000379:methods*; D011379:Prognosis; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000032:analysis / Q000276:immunology; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000032:analysis; D013274:Stomach Neoplasms / Q000235:genetics / Q000378:metabolism* / Q000401:mortality / Q000628:therapy*; D016159:Tumor Suppressor Protein p53 / Q000032:analysis; D042461:Vascular Endothelial Growth Factor A / Q000032:analysis / Q000096:biosynthesis
chemical_list: D000911:Antibodies, Monoclonal; D014408:Biomarkers, Tumor; D015820:Cadherins; D051177:Catenins; D019253:Proto-Oncogene Proteins c-bcl-2; D018719:Erb-b2 Receptor Tyrosine Kinases; D016159:Tumor Suppressor Protein p53; D042461:Vascular Endothelial Growth Factor A